Allworth Financial LP reduced its stake in ARK Genomic Revolution ETF (BATS: ARKG) by 37.1% in the fourth quarter, according to Holdings Channel. The fund owned 896 shares of the company’s stock after selling 529 shares during the quarter. Allworth Financial LP’s holdings in ARK Genomic Revolution ETF were valued at $29,000 as of its most recent SEC filing.
Other large investors also made moves with ARK Genomic Revolution ETF. Baird Financial Group Inc. increased its position by 18.9% in the first quarter, now owning 42,002 shares worth $1,929,000. High Net Worth Advisory Group LLC saw an 80.9% increase in their stake, now owning 1,118 shares worth $51,000. Ancora Advisors LLC and Certified Advisory Corp also saw increases in their holdings, while Captrust Financial Advisors grew its stake by 282.2% in the second quarter.
The stock performance of ARK Genomic Revolution ETF saw an opening price of $25.90 on Monday, with a 50-day simple moving average of $29.38 and a 200-day simple moving average of $28.58.
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that focuses on companies in the genomics industry. Launched on Oct 31, 2014, ARKG is managed by ARK.
For more information on hedge fund holdings and insider trades for ARK Genomic Revolution ETF, visit HoldingsChannel.com for the latest 13F filings and reports.
Stay updated on ARK Genomic Revolution ETF news and ratings by subscribing to MarketBeat.com’s FREE daily email newsletter.